Blue Sail Medical released its 2026 half-year report, showing operating revenue of 3.71 billion yuan, up 33.3 percent year on year. Net profit attributable to the parent swung from a loss of 135 million yuan in the same period last year to a profit of 95.68 million yuan. Net profit attributable to the parent after deducting non-recurring items swung from a loss of 210 million yuan a year earlier to a profit of 79.72 million yuan. Operating cash flow was 421 million yuan, up 25.5 percent year on year. In the second quarter, operating revenue was 2.08 billion yuan, up 59.7 percent year on year, and net profit attributable to the parent swung from a loss of 212 million yuan a year earlier to a profit of 94.72 million yuan. Around 60 percent of revenue in the company's cardiovascular and cerebrovascular business came from overseas operations, up about 25 percent year on year, while revenue in the health protection business rose about 36 percent from a year earlier and successfully returned to profitability.
Blue Sail Medical Co LtdSwings to profit with strong revenue growth and improved margins
